Chromosome 15q BP3 to BP5 deletion is a likely locus for speech delay and language impairment: Report on a four-member family and an unrelated boy by Piero Pavone, Martino Ruggieri, Simona D Marino, Giovanni Corsello, Xena Pappalardo, Agata Polizzi, Enrico Parano, Catia Romano, Silvia Marino, Andrea Domenico Pratic\uf2, Raffaele Falsaperla
Mol Genet Genomic Med. 2020;8:e1109.    |  1 of 11
https://doi.org/10.1002/mgg3.1109
wileyonlinelibrary.com/journal/mgg3
Received: 17 July 2019 | Revised: 11 December 2019 | Accepted: 16 December 2019
DOI: 10.1002/mgg3.1109  
O R I G I N A L  A R T I C L E
Chromosome 15q BP3 to BP5 deletion is a likely locus for speech 
delay and language impairment: Report on a four-member family 
and an unrelated boy
Piero Pavone1,2  |   Martino Ruggieri2 |   Simona D. Marino3 |   Giovanni Corsello4 |   
Xena Pappalardo5 |   Agata Polizzi6 |   Enrico Parano5 |   Catia Romano3 |   Silvia Marino3 | 
Andrea Domenico Praticò2 |   Raffaele Falsaperla3
This is an open access article under the terms of the Creat ive Commo ns Attri butio n-NonCo mmerc ial-NoDerivs License, which permits use and distribution in any medium, 
provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
1Unit of Clinical Pediatrics, University 
Hospital “Policlinico-Vittorio Emanuele”, 
University of Catania, Catania, Italy
2Unit of Rare Diseases of the Nervous 
System in Childhood, Department of 
Clinical and Experimental Medicine, 
Section of Pediatrics and Child 
Neuropsychiatry, University of Catania, 
Catania, Italy
3Units of Pediatrics and Pediatric 
Emergency, University Hospital 
“Policlinico-Vittorio Emanuele”, Catania, 
Italy
4Units of Pediatrics and Neonatal Intensive 
Care, Department of Health Promotion of 
Maternal-Infantile Care and of Excellence 
Internal and Specialist Medicine “G. 
D'Alessandro” [PROMISE], University of 
Palermo, Palermo, Italy
5National Council of Research, Institute 
for Research and Biomedical Innovation 
(IRIB), Unit of Catania, Catania, Italy
6Chair of Pediatrics, Department of 
Educational Sciences, University of 
Catania, Catania, Italy
Correspondence
Piero Pavone, Unit of Clinical Pediatrics, 
University Hospital “Policlinico-Vittorio 
Emanuele”, University of Catania, Via S. 
Sofia 78, 95125–Catania, Italy.
Email: ppavone@unict.it
Abstract
Background: Deletions in chromosome 15q13 have been reported both in healthy 
people and individuals with a wide range of behavioral and neuropsychiatric distur-
bances. Six main breakpoint (BP) subregions (BP1-BP6) are mapped to the 15q13 
region and three further embedded BP regions (BP3-BP5). The deletion at BP4-BP5 
is the rearrangement most frequently observed compared to other known deletions in 
BP3-BP5 and BP3-BP4 regions. Deletions of each of these three regions have previ-
ously been implicated in a variable range of clinical phenotypes, including minor 
dysmorphism, developmental delay/intellectual disability, epilepsy, autism spectrum 
disorders, behavioral disturbances, and speech disorders. Of note, no overt clinical 
difference among each group of BP region deletions has been recorded so far.
Methods: We report on a four-member family plus an additional unrelated boy af-
fected by a BP3-BP5 deletion that presented with typical clinical signs including 
speech delay and language impairment. A review of the clinical features associated 
with the three main groups of BP regions (BP4-BP5, BP3-BP5, and BP3-BP4) dele-
tions is reported.
Results: Array-CGH analysis revealed in the mother (case 1) and in her three chil-
dren (cases 2, 3, and 4), as well as in the unrelated boy (case 5), the following rear-
rangement: arr (hg19) 15q13.1-q13.3 (29.213.402–32.510.863) x1.
Conclusion: This report, along with other recent observations, suggests the hypoth-
esis that the BP region comprised between BP3 and BP5 in chromosome 15q13 is 
involved in several brain human dysfunctions, including impairment of the language 
development and, its deletion, may be directly or indirectly responsible for the speech 
delay and language deficit in the affected individuals.
K E Y W O R D S
BP3-BP5 deletion, chromosome 15 q13, developmental delay, language impairment, speech delay
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1 |  INTRODUCTION
The long arm of chromosome 15 (15q) plays an important 
role in human neurobehavioral development: several chromo-
somal abnormalities have been often associated with a wide 
range of neuropsychiatric disorders. Pure, isolated 15q dele-
tions have been rarely recorded usually in association with 
severe clinical phenotypes. Solmaz, Durmaz, Braekeleer, 
Cogulu, and Ozkinay (2016) described an 11-year-old girl 
with a 15q deletion who had multiple congenital anomalies. 
This girl was born with a cleft palate, hip dislocation, crossed 
renal ectopic malformations, and dysmorphic features mainly 
affecting the face and limbs. Additionally, it should be noted 
that she showed speech problems. The 15q11-q13 locus is 
particularly susceptible to genomic rearrangements as a result 
of the nonallelic homologous recombination (NAHR) of Low 
Copy Repeats (LCRs) elements, also known as segmental du-
plications (SDs), mapped in the six breakpoints (BP1-BP6) 
regions, leading to recurrent structural variations, such as du-
plication or deletion events (Ehmke et al., 2017; Szafranski et 
al., 2010; Van Bon, Mefford, & de Vries, 2010). Actually, the 
prevalence of 15q13 microdeletions, in healthy individuals, 
is around 0.02%, whereas in individuals with intellectual dis-
ability, seizures, schizophrenia, and autism spectrum disor-
ders (ASD), is as high as 0.2 to 1%–2% (Van Bon et al., 2010]. 
Clinical manifestations of deletions occurring on 15q11-q13 
may considerably range, showing a relatively high penetrance 
and variable clinical expressions of behavioral and neuropsy-
chiatric disturbances (Sharp et al., 2008). The 15q11-q13 re-
gion includes six BP ranging from BP1 to BP6, and three 
further BPs, from BP3 to BP5. Deletions involving BP4-BP5 
occur more frequently as compared to BP3-BP4, and to (the 
larger BP interval) BP3-BP5 (Sahoo et al., 2005; Sharp et al., 
2008; Van Bon et al., 2009; Wandstrat, Leana-Cox, Jenkins, 
& Schwartz, 1998; Williams et al., 2012). When the fragment 
deleted comprises the BP4-BP5, BP3-BP4, and BP3-BP5 re-
gions, the clinical phenotype usually ranges from healthy to 
severely affected individuals with microcephaly and macro-
cephaly, developmental delay/intellectual disability (DD/ID), 
behavioral disturbances, autism spectrum disorders (ASD), 
epileptic seizures, attention deficit hyperactivity disorder 
(ADHD), and aggressiveness, in association or not with dis-
tinct dysmorphic features (Ehmke et al., 2017; Sharp et al., 
2008; Van Bon et al., 2010). Recently, particular emphasis 
has been paid to the spectrum of language disabilities, as 
one of the presenting features of the 15q deletion syndrome 
(Pettigrew et al., 2015).
We hereby report on a four-member family plus an ad-
ditional unrelated boy all harboring a BP3-BP5 deletion, 
who had a wide range of congenital malformations in asso-
ciation with mild-to-moderate intellectual disability, behav-
ioral disturbances, speech delay, and language impairment, 
thus showing that speech abnormalities is likely to represent 
(whether or not in combination with mild/moderate intellec-
tual disability) as one of the presenting feature of the 15q 
deletion syndrome. A review of the spectrum of clinical fea-
tures in the 15q deletion syndrome is reported focusing on the 
main differences and similarities in each BP deleted group, 
including BP4-BP5, BP3-BP4, and BP3-BP5.
2 |  CLINICAL REPORT
2.1 | Case 1
This 37-year-old woman was the mother of three children 
(cases 2 to 4). Her husband is 43-years old and is healthy and 
his speech is normal. Her family history was unremarkable. 
She was born with congenital pulmonary anomalous venous 
lobar return syndrome (scimitar syndrome) undergoing early 
cardiac surgical correction. Her developmental milestones 
were normal with the exception of speech delay. At her most 
recent re-evaluation the height was 160 cm (25/50th percen-
tile), the weight was 75 kg (90/97th percentile), and the oc-
cipitofrontal circumference (OFC) was 60  cm (above 97th 
percentile). She lives a normal life with a normal cognitive 
capacity (IQ 72; IQV 55; WISC III) but with impairment in 
expressive language. She shows difficulties in putting words 
together into a sentence, and her speech is barely intelligible. 
She is irritable and impulsive. During her three pregnancies, 
she denied having had any infectious disease or smoking, or 
using drugs or drinking alcohol.
The main clinical features in the four members of this 
family and in the unrelated affected boy are summarized in 
Table 1.
2.2 | Case 2
This 12-year-old girl is the first of three siblings. She was 
born at 35  weeks of gestation by cesarean section after an 
uneventful pregnancy. Her birth weight was 2,800  g (50th 
percentile), height was 50 cm (75th percentile), and her OFC 
was 37 cm (90th percentile). Her developmental milestones 
were delayed: her speech started at the age of 4 years when 
she started speech therapy. She followed a language course 
which still pursues with fairly good results. Her school per-
formance is hardly sufficient, but her teachers complained 
of hyperactivity during the everyday lessons and of poor at-
tention. At her most recent evaluation general physical ex-
amination reveals that her weight is 80 kg (<97th percentile), 
height is 180  cm (90th percentile), and the OFC is 57  cm 
(above 97th percentile). Her abundant fat is localized to the 
upper body above the waist. There are minor dysmorphic 
features, including a large head with a high forehead, thin 
lips, supernumerary and dyschromic teeth, and abundant hair 
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over the entire body with a linear trend on the shoulders. 
Ultrasonographic examination of the heart and internal or-
gans is normal as is the genital organs; the menstrual cycle 
had already started. Neurological examination reveals mild/
moderate cognitive delay (I.Q. scores were 41 and IQV 35 
by means of WISC-III) with behavioral disturbances (i.e., 
hyperactivity and an anxious state). Neuropsychiatric testing 
gave the following results: ADHD Denver Scale Recording 
scored 87 (n.v., 50–55); the Depression Baylor Scale scored 
92 (n.v., 60–65); and the Anxiety Stanford Scale scored 95 
(n.v., 60–65). Her language disturbances consist in a poor 
expressive vocabulary with scant sentences and inadequate 
word structures. Test for reception of grammar (TROG2) 
gave the following results: she passed 14 blocks (standard 
score 97). Routine laboratory analyses, including blood 
count, electrolytes, plasma and urinary amino acids, thyroid 
testing, organic acid plasma, and total cholesterol, are normal.
2.3 | Case 3
This 8-year-old boy is the second born to the mother re-
ported as case 1 and sibling of cases 2 and 4. He was born at 
37 weeks of gestation by cesarean section after an uncompli-
cated pregnancy. His birth weight was 3,000 g (50th percen-
tile), height was 50 cm (50th percentile), and the OFC was 
37 cm (97th percentile). The APGAR scores were 7 and 9 at 
1 and 5  min, respectively. Developmental milestones were 
attained normally with the exception of language, which 
started at the age of 4 years. The child, because of macro-
cephaly and language delay, was referred to this Institution 
in Catania for diagnostic work-up. At the Leiter-R test he 
attained FluidReas 70 and brief I.Q. 72. Speech and physi-
cal therapies were soon started which resulted in a bettering 
of the speech production and of the receptive language. At 
the age of 7 years, a new psychological evaluation revealed 
mild intellectual disability (WISC-III  =  IQV. 55, IQP. 65; 
IQT. 54) and behavioral disturbances, mainly consisting in 
difficulties in focusing attention and in following rules with 
provocative opposite behavior and low frustration tolerance. 
Socialization was good. At school, he was helped by support. 
The parents recalled that he had a single partial seizure at 
the age of 3 years. At his most recent clinical reevaluation 
physical examination reveals that his general conditions are 
good. His weight is 25 kg (25th percentile), height is 125 cm 
(25th percentile), and the OFC is 56 cm (90–97th percentile). 
He shows a large head with a high forehead, the eyelids are 
medially sparse, the philtrum is flat, and the lips thin with a 
sub-labial crease. Supernumerary teeth, bilaterally inverted 
nipples, and a single transverse palmar crease are also noted. 
Neurological examination reveals mild cognitive delay with 
a severe language impairment. Routine laboratory analy-
ses, including blood count, electrolytes, plasma and urinary 
amino acid, thyroid testing, organic acids, plasma purines, 
and total cholesterol, are normal. No anomalies are found 
at the cardiac ultrasonography. Internal organs and genital 
organs are normal. EMG, NCV, ophthalmological examina-
tion, and brain MRI are unrevealing. EEG shows the presence 
of multiple spikes and waves in the bilateral frontal regions. 
Currently, at age 8 years, the child weighs 24 kg (50th per-
centile), the height is 130  cm (75th percentile), and OFC 
is 56 cm (above 97th percentile). Neuropsychiatric testing, 
by means of language scale evaluating system IV-revised, 
revealed difficulties in production of spoken language, in 
T A B L E  1  Main clinical features of the mother, three siblings (number 1 to 4), and of an unrelated boy (number 5). Language Impairment 
from mild to notable (+ to +++); SD: Down syndrome. Intelligence Quotient (IQ Wisc III)
Case 1 2 3 4 5
Gender F F M M M
Age/years 37 12 8 5 15
Dysmorphisms No Yes Yes SD No
High forehead No + + No No
Supernumerary teeth No + + No No
Large head + + + No +
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words and sentences comprehension and structuration. The 
language comprehension through TROG2 has been evalu-
ated to be under the normal range with poor verbal memory 
and low rhythm of language elaboration.
2.4 | Case 4
This 5-year-old boy is the third born of the mother reported 
as case 1. A screening test for Down's syndrome displayed 
positive results but the parents decided to proceed with 
pregnancy. Since the 29th gestational week, a growth re-
striction was noticed, and the child was born at 35 weeks 
of gestation by cesarean section. His birth weight was 
2.440 g (25–50th percentile), height was 48 cm (25th per-
centile), and head circumference was 34 cm (25th percen-
tile). At birth, an unbalanced atrioventricular septal defect 
was diagnosed and the child underwent cardiac surgery at 
age 5 months with definitive correction. Clinical diagno-
sis of Down's syndrome was made at birth and confirmed 
by chromosomal analysis (47, XY + 21). Developmental 
milestones were delayed. At his most recent reevaluation, 
the child had the classical features of Down's syndrome. 
The weight is 15 kg (3th percentile), height is 100 cm (3th 
percentile), and the OFC is 47 cm (below 3rd percentile). 
Frequent episodes of irritability and impulsivity are re-
corded. Of note, intellectual disability is recoded between 
mild and moderate, speech is completely absent, the child 
does not pronounce any word, while the socialization skills 
are good. Griffith Mental Development Scale (GMDS) 
showed development assessment lower than normal in all 
the domain (<50). Leiter-R test brief IQ 58. No epileptic 
seizures are recorded. Laboratory analysis, EEG, and brain 
MRI are normal.
2.5 | Case 5
A 15-year-old boy unrelated to the upper mentioned family.
The proband's mother 45 years old is nurse and the father 
48 years old is hydraulic. Both are healthy and both have nor-
mal cognitive level and normal speech. The proband's brother 
is 17 years old. He attends normal school with good perfor-
mance and normal speech.
The mother denied having had clinical problems during 
gestation. The child was born at term by spontaneous de-
livery with birth weight of 4 kg, height of 52 cm, and head 
circumference of 36  cm (all above the 97th percentile). 
He was first referred to this Institution at age 4 years be-
cause of two episodes of complex febrile seizures, which 
occurred within a period of time of 2  weeks. His motor 
developmental milestones were reached normally, while 
language was delayed: he was able to express single words 
only after 36  months. He used 3–4 word phrases at age 
5 years. At this age, he was referred again to this Institution 
for a work-up related to his mild intellectual disability and 
his language delay. Laboratory and neurodevelopmen-
tal evaluations were carried out including EEG and brain 
MRI, which were normal. Physical examination revealed 
no dysmorphic features with no physical anomalies. Motor, 
speech, and language treatment was undertaken and contin-
ued afterward with relatively good results. Currently, he at-
tends a regular school course with a special needs teacher. 
The teachers complain about immature behavior with ep-
isodes of impulsivity, irritability, and an attention deficit 
disorder. At his last reevaluation, at age 15 years, he weighs 
60  kg (50th percentile), his height is 170  cm (50th), and 
the OFC 58.5 cm (above 97th percentile). Physical exam-
ination is unrevealing. Internal organs ultrasonography is 
normal. Neuropsychiatric evaluation by means of WISC III 
recorded the following scores: IQ 62 and IQV 55. TROG2 
test gave the following result: he passed 18 blocks (stan-
dard score 97). Language evaluation revealed difficulties 
in formulating sentences, in expressive vocabulary, and in 
word structures.
2.6 | Genetic testing
2.6.1 | Microarray testing and data analysis
The analysis was driven after a full diagnostic work-up for 
ID, speech difficulties, and behavioral disturbances in case 
3 (then extended to the members of family 1) and in case 5 
of the family 2. Recombination breakpoints were detected 
using high-resolution 8x60K Human Genome CGH mi-
croarray (Agilent Technologies). Array experiments were 
performed as recommended by the manufacturer (Agilent 
Technologies). Proband DNA was labeled with Cy5 and ref-
erence DNA (human DNA Promega) with Cy3. Purification, 
hybridization, and washing steps were performed according 
to the manufacturer's instructions. Data visualization and 
analysis were performed with Sure Scan microarray Scanner 
G2600D (Agilent), Feature Extraction software (Agilent), 
and Agilent Cytogenomics Software Edition 2.5.
3 |  RESULTS
Array-CGH analysis revealed the following rearrangement: 
arr (hg19) 15q13.1-q13.3 (29.213.402–32.510.863)  ×  1. 
These results were recorded in the mother (case 1) and in her 
three siblings (cases 2, 3, and 4) as well as in the unrelated 
boy (case 5). (Figure 1). No copy number variants were re-
corded by array-CGH analysis, which was carried out on the 
patient's husband and in the parents of the unrelated boy.
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4 |  DISCUSSION
In the present family, all three children and their mother har-
bored, by means of array-CGH analysis, a partial deletion of 
the long arm of chromosome 15 extending 3.297 Mb from nt 
29.213.402 to nt 32.510.863. A similar deletion was recorded 
in an additional unrelated boy. The deletion was located in 
the 15q13 region, specifically in the BP3-BP5 locus. The 
mother at birth had congenital anomalous venous return pul-
monary syndrome (i.e., scimitar syndrome), corrected soon 
after birth. Scimitar syndrome is a very rare disorder consist-
ing of a combination of cardiopulmonary anomalies with an 
anomalous right pulmonary venous return, which is located 
mostly in the anterior vena cava (Benjouad et al., 2016; 
Holt, Berdon, Marans, Griffiths, & Hsu, 2004; Ruggieri et 
al., 2003). The youngest child of the four-member family 
was affected by Down's syndrome (DS) and had typical phe-
notypic features including congenital heart disorder (atrio-
ventricular septal defect) and karyotype 47chr, XY + 21. Of 
note, in the 5-year-old child, the language skills had not yet 
started. The main features recorded in the family members 
and in the unrelated boy (summarized in Table 1) consisted 
of cardiac anomalies recorded in 2 out of 5, dysmorphic fea-
tures recorded in 3 out of 5, and OFC above the 97th per-
centile recorded in 4 out of 5 patients. Additional features 
consisted of intellectual disabilities mainly mild recorded in 
4 out 5 individuals, speech delay, language impairment, and 
behavioral disturbances recorded in all patients.
A deletion between BP1-BP3 has been reported in in-
dividuals with Prader-Willi syndrome and Angelman syn-
drome (Makoff & Flomen, 2007; Varela, Kok, Otto, & 
Koiffmann, 2004; Varela, Kok, Setian, Kim, & Koiffmann, 
2005), whereas individuals with a deletion in the BP3-BP4, 
BP4-BP5, and BP3-BP5 regions show a variable clinical 
expression that is mainly characterized by minor dysmor-
phic features, language deficits, and neurodevelopmental 
and neuropsychiatric disorders, including DD/ID, epilepsy, 
ASD, schizophrenia, mood disorders, and ADHD. Lowther 
et al. (2015), in a review of individuals presenting with a 
15q13.3 deletion, identified 246 cases consisting of 133 
children and 113 adults. Moreover, seven adults driven from 
a cohort of patients affected by schizophrenia and tetralogy 
of Fallot were enrolled. In the control group, consisting 
of 23,838 individuals, no cases of BP4-BP5 deletion were 
found. In the majority of the examined patients, the deletion 
involved the region BP4-BP5 (94%), whereas the region 
BP3-BP4 and the largest region BP3-BP5 were involved in 
5.4% and in 3.1% of the cases, respectively. In the 133 chil-
dren, the reason for the diagnostic work-up regarded mul-
tiple congenital anomalies and/or DD/ID (n = 64 of 105; 
61.0%), epilepsy (n = 31 of 105; 29.5%), or ASD (n = 10 
of 105; 9.5%). In this group, Lowther et al. (2015) reported 
behavioral problems including ADHD, aggression/rage, 
hyperactivity, self-mutilation, poor concentration, poor 
attention, impulsivity, and other similar features, as the 
most prevalent clinical manifestations (n  =  46, 34.6%). 
Moreover, 30 (13.5%) had speech problems, 18 (13.5%) 
hypotonia, 10 (7.5%) brain abnormalities as shown by 
MRI, and 12 (9.5%) mood disorders. Analyzing the clinical 
features of each patients of the groups with deletions in 
BP4-BP5, BP3-BP4, and BP3-BP5, no relevant differences 
were found (Lowther et al., 2015). Sharp et al. (2008) were 
among the firsts to report clinical observations of patients 
presenting with a BP4-BP5 deletion: all of the nine patients 
reported manifested variable degrees of facial dysmorphic 
features and mild-to-moderate grade of mental retardation 
F I G U R E  1  Graphic representation of 15q13.3 CNV deletion retrieved from UCSC Genome Browser on Human Feb. 2009 (GRCh37/hg19) 
Assembly. Green boxes represent main genes included in the region defined by breakpoints 4–5 (BP4, BP5)
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(9/9 cases). Epilepsy and/or EEG anomalies were found in 
seven of the nine patients.
In our systematically review, we reported the phenotype 
analysis of patients with the 15q13.1 deletion, selected ac-
cording to the region involved (BP4-BP5, BP3-BP4, and 
BP3-BP5) and summarized in Table 2 (Ben-Shachar et al., 
2009; Dibbens et al., 2009; Endris et al., 2010; Hassfurther, 
Komini, Fischer, & Leipoldt, 2016; Helbig et al., 2009; Jähn 
et al., 2014; Lowther et al., 2015; Masurel-Paulet et al., 2010; 
Miller et al., 2009; Pagnamenta et al., 2009; Pettigrew et al., 
2015; Rosenfeld et al., 2011; Sharp et al., 2008; Shinawi et 
al., 2009; Van Bon et al., 2009; Ziats et al., 2016 and present 
cases). The BP4-BP5 region was more susceptible to flank-
ing. In this cohort (see Table 2), we collected 125 individuals 
presenting with behavioral disturbances, DD/ID, and mild–
moderate intellectual disability, and speech disorders, which 
were reported in 42.4%, 68.8%, and 36%, respectively. Other 
recurrent clinical manifestations were epilepsy in 32% and a 
small or large OFC in 19.2% and 16.8% of the cases, respec-
tively. Other features included ASD, reported in 12.8%, and 
dysmorphisms, reported in 16%. Facial dysmorphic features 
were minor, not specific, and did not affect particular areas 
of the face.
Patients with a BP3-BP5 deletion are uncommonly re-
ported. Rosenfeld et al. (2011), in a cohort of 34,046 samples 
who were submitted for a diagnostic work-up, identified four 
individuals with deletions involving the BP3-BP4 region and 
one with deletions involving the BP3-BP5 region. In our re-
view of 19 patients presenting with BP3-BP5 deletions (see 
Table 2), dysmorphic features were reported in 21%, DD/ID 
and mild–moderate ID in 73.6%, behavioral disturbances in 
68.4%, speech difficulties in 47.3%, epilepsy in 31.5%, and 
large head in 36.8.%. Two cases of ASD and small head have 
also been reported (10.5%).
Patients affected by a BP3-BP4 microdeletion are rarely 
reported. The five reported patients (see Table 2) showed 
DD/ and mild/moderate ID as more frequently reported mani-
festation (100%), followed by dysmorphic features (60%) and 
small head (60%). Speech disorder, epilepsy, and large head 
were reported in 40% of the cases.
The role of genes in the clinical expression of the 
15q13.3 deletion is widely debated. Heterozygous dele-
tions of chromosome region 15q13.3 more often involve 
a 1.5 segment between BP4 and BP5, which contains sev-
eral genes (Figure 1); that is, ARHGAP11B, MTMR15, 
MTMR10, TRPM1, KLF13, OTUD7A, and CHRNA7, and 
a miRNA gene (hsa-mir-211) (Endris et al., 2010). The 
CHRNA7 gene has been reported as a major candidate 
gene for clinical expression of the deletion. This gene 
encodes for the neuronal alpha 7 nicotinic acetylcholine 
receptor, a synoptic ion channel protein that mediates 
neuronal signal transmission. This gene has been often as-
sociated with patients affected by epileptic seizures and 
patients with schizophrenia (Masurel-Paulet et al., 2010). 
However, CHRNA7, as responsible for the 15q13.3 mi-
crodeletion features, remains to be questionable. TRPM1 
has also been implicated in the clinical expression of the 
15q13.3 deletion. TRPM1 belongs to the family of tran-
sient receptor potential channels that encode a calcium 
permanent channel, and it is related to bipolar cells (Audo 
et al., 2009; Coe et al., 2014; Lamego, Moreira, & Bastos, 
2018). It has been implicated in visual impairment in chil-
dren with a homozygous 15q13.3 deletion. The OUT deu-
biquitinase 7A is a protein encoded by the OTUD7A gene, 
and it may have a possible tumor suppressor function. In 
mice, it has been shown to regulate the dendritic spine 
density and glutamatergic synaptic transmission (Bishop, 
North, & Donlan, 1995). ARHGAP11B in the embryonic 
mouse neocortex promotes basal progenitor generation 
and can act by increasing the cortical plate area, stimu-
lating gyrification. ARHGAP11B is derived from partial 
duplication of the ARHGAP11A gene, which encodes a 
Rhoguanosine triphosphatase-activating protein (Florio 
et al., 2015; Yin et al., 2018). The protein coded by the 
Kruppel-like transcription factor 13 (KLF13) gene is a 
member of the Kruppel-like family of zinc finger pro-
teins, which is a candidate for regulating cardiac gene ex-
pression and heart morphogenesis (Lavallée et al., 2006; 
Valbonesi et al., 2015). The myotubularin-related protein 
10 (MTMR10) and MTM315 genes, also known as FAN1 
(FANCD2- and FANCI-associated nuclease 1), encodes 
an endo- and exonuclease, which are involved in DNA 
interstrand cross-link repair (Forsingdal, Fejgin, Nielsen, 
Werge, & Nielsen, 2016). Mutations in both genes typ-
ically cause karyomegalic interstitial nephritis. Finally, 
a gene encoding a small noncoding RNA, termed miR-
211, has been shown to act as a tumor metabolic switch 
(Bekenstein et al., 2017) and more recently to act as a key 
regulator of cholinergic imbalances and epileptiform ac-
tivity (Mazar et al., 2016). The gene or genes responsible 
for the features presented by individuals with the 15q13.3 
deletion are yet to be identified.
In reporting the features of the four members of this 
family and of the unrelated boy, we were impressed by 
the language impairment that was not compatible with the 
intellectual disability, which conversely was mild and/or 
moderate. We think that the 15q13.3 region must have a 
direct or indirect role in language development and its de-
letion is likely to be involved in language disorders. Ben-
Shachar et al. (2009) screened, as diagnostic testing, 8,200 
samples and they found 19 individuals with a BP4-BP5 
deletion and 1 with a BP3-BP5 deletion. Among these, 14 
children showed at least mixed expressive and receptive 
language delay. The language impairment was more pro-
nounced than the developmental delay in gross and fine 
motor skills. Moreover, a 6.5-year-old girl was reported by 
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Ehmke et al. (2017) who showed a de novo nonsense mu-
tation in ZBTB18 plus a de novo 15q13.3 microdeletion. 
She manifested absent speech, global developmental delay, 
seizures unresponsive to treatment, ataxia, hypotonia, and 
minor dysmorphisms. Pettigrew et al. (2015), in a screening 
cohort of 85 children with language difficulties, detected 
a BP3-BP5 deletion in a child with language impairment 
in the absence of ID or other anomalies. This observation 
leads the authors to hypothesize the deletion as one of the 
putative cause of language disorders. The reported family 
and the unrelated boy may be a further contribution to this 
hypothesis. In fact, aside from the other features frequently 
reported with the BP3-BP5 deletion, the four members of 
the present family and the unrelated boy showed a nota-
ble speech delay and language impairment that was more 
relevant compared to the intellectual disability, which was 
mainly mild/moderate in the individuals with this deletion. 
One of the members of the family, the 5-year-old child with 
DS, showed global absence of language, which is an un-
usual feature in DS children (Bishop et al., 1995, Kent & 
Vorperian, 2013).
In conclusion, the region between BP3 and BP5 is likely 
directly or indirectly involved in human language develop-
ment, and the deletion may have a causal effect in association 
to the cognitive dysfunction on language impairment in af-
fected individuals. Limitations on this observation are related 
to the specificity of this region which is low given that lan-
guage delays and impairments are commonly seen in nearly 
all and even in all types of CNVs and this region is associ-
ated to other features including global intellectual disability. 
Anyway, we have noted that in the here reported patients the 
language impairment was more expressed compared to the 
cognitive dysfunction, thus leading to hypothesis advanced 
by Pettigrew et al. (2015) on the directly or indirectly causal 
role of this deletion on the etiology of language disorders. 
This report supports the hypothesis of Pettigrew et al. (2015) 
on the causal role of this deletion in the etiology of language 
disorders.
Unfortunately, the language disorder is not the only clin-
ical manifestation of this disorder, which is frequently found 
to be linked to other features, such as mild/moderate intellec-
tual disabilities, behavioral impairments, dysmorphisms, and 
congenital anomalies.
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